We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Innospec Initiates Site Construction for DRA Manufacturing
Read MoreHide Full Article
Innospec Inc. (IOSP - Free Report) has started construction on its new facility to make Drag Reducing Agents (DRAs). The site, located at Pleasanton, TX, is an extension of the existing Innospec site. The project is well advanced and the company expects beneficial production in the second half of 2018.
Besides being a fast-growing, exciting, cutting-edge technology, DRAs offer improved productivity as well as low costs for customers. This latest addition is complementary to the company’s existing portfolio that will allow it to serve its customers globally.
These products reduce the turbulent flow of liquids in a cost-effective manner to improve pipeline throughput and reduce the energy required for pumping. The technology can be applied to crude oils and to fuels including diesel.
Shares of Innospec have gained 22.3% over a year, outperforming the industry’s 15% gain.
The company reported adjusted earnings of $1.02 per share for the first quarter of 2018, beating the Zacks Consensus Estimate of 98 cents. Revenues went up 23% year over year to $360.7 million in the quarter.
Innospec is seeing healthy customer activity across all of its core businesses. The company said that it will remain focused on further improving margins in Performance Chemicals and other strategic businesses to boost profitability. Innospec expects its margin-improvement programs to deliver enhanced profitability later this year.
FMC Corp has an expected long-term earnings growth rate of 13.6%. Its shares have gained around 22.4% over a year.
Huntsman has an expected long-term earnings growth rate of 8.3%. Its shares have moved up around 24.8% over a year.
Chemours has an expected long-term earnings growth rate of 15.5%. Its shares have gained around 20.2% over a year.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early. See Zacks' 3 Best Stocks to Play This Trend >>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Innospec Initiates Site Construction for DRA Manufacturing
Innospec Inc. (IOSP - Free Report) has started construction on its new facility to make Drag Reducing Agents (DRAs). The site, located at Pleasanton, TX, is an extension of the existing Innospec site. The project is well advanced and the company expects beneficial production in the second half of 2018.
Besides being a fast-growing, exciting, cutting-edge technology, DRAs offer improved productivity as well as low costs for customers. This latest addition is complementary to the company’s existing portfolio that will allow it to serve its customers globally.
These products reduce the turbulent flow of liquids in a cost-effective manner to improve pipeline throughput and reduce the energy required for pumping. The technology can be applied to crude oils and to fuels including diesel.
Shares of Innospec have gained 22.3% over a year, outperforming the industry’s 15% gain.
The company reported adjusted earnings of $1.02 per share for the first quarter of 2018, beating the Zacks Consensus Estimate of 98 cents. Revenues went up 23% year over year to $360.7 million in the quarter.
Innospec is seeing healthy customer activity across all of its core businesses. The company said that it will remain focused on further improving margins in Performance Chemicals and other strategic businesses to boost profitability. Innospec expects its margin-improvement programs to deliver enhanced profitability later this year.
Innospec Inc. Price and Consensus
Innospec Inc. Price and Consensus | Innospec Inc. Quote
Zacks Rank & Other Stocks to Consider
Innospec is a Zacks Rank #2 (Buy) stock.
Some other top-ranked companies in the basic materials space worth considering are FMC Corporation (FMC - Free Report) , Huntsman Corporation (HUN - Free Report) and The Chemours Company (CC - Free Report) . All three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
FMC Corp has an expected long-term earnings growth rate of 13.6%. Its shares have gained around 22.4% over a year.
Huntsman has an expected long-term earnings growth rate of 8.3%. Its shares have moved up around 24.8% over a year.
Chemours has an expected long-term earnings growth rate of 15.5%. Its shares have gained around 20.2% over a year.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>